<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24655909</identifier>
<setSpec>1578-8865</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Hormigo Pozo, A</dc:author>
<dc:author>Mancera Romero, J</dc:author>
<dc:type>Editorial</dc:type>
<dc:language>es</dc:language>
<dc:date>2014 Mar </dc:date>
<dc:title xml:lang="es">Seguridad cardiovascular de los nuevos f√°rmacos para la diabetes tipo 2.</dc:title>
<dc:title xml:lang="en">[Cardiovascular safety of new type 2 diabetes drugs].</dc:title>
<dc:publisher>Semergen</dc:publisher>
</metadata>
</record>
</pubmed-document>
